EU Trans Reg ID: 221589017973-83
ACT-EU Initiative
The EU EYE has been appointed as an ad hoc member to the Multistakeholder Platform Advisory Group, which provides strategic advice regarding the ACT EU workplan; operational advice for ACT EU initiatives; and identifying experts, stakeholder priorities and engagement methodology. The EU EYE will be represented by Luc van Os.
The ACT-EU initiative is a joint effort by the European Commission, the Heads of Medicines Agencies, and the European Medicines Agency to transform the clinical trials landscape in the European Union. The aim is to foster innovation, quality, and efficiency in clinical research, and to better integrate it with the European health system.
Member of the Health Technology Assessment (HTA) Stakeholder Network
The EU EYE has been appointed by the European Commission as a member of the Health Technology Assessment (HTA) Stakeholder Network. The organisation will be represented by João Barbosa Breda.
The active participation of the EU EYE in the implementation of HTA Regulation will ensure a balanced representation in terms of relevant know-how and geographical coverage. The HTA Stakeholder Network has been established to assist the European Commission in the implementation of the HTA Regulation across the EU. The selected organisations will support the work of the Member State Coordination Group on HTA and its subgroups.
Increasing awareness about the challenges faced by our specialties at national level can benefit eye patients as a whole.
Joint statement on European
Health Data Space
Recommendations to ensure the full potential of digital transformation
Medical Terms Simplifier & Regulatory Terms Explained
View the terms outlined below
Shortage of medicines
shortages in the EU
Interested in eye health?
From bench to bedside
Eye for Experts
A platform that informs and assists our members when applying to calls for external advice in Working Groups, Panels and Scientific Committees of the European Commission and EU agencies.
